Abstract
In the late1990s, reacting to the outbreak of bovine spongiform encephalopathy (BSE) in the United Kingdom that caused a new variant of Creutzfeldt-Jakob disease (vCJD) in humans, manufacturers withdrew bovine heparin from the market in the United States. There have been growing concerns about the adequate supply and safety of porcine heparin. Since the BSE epidemic has been declining markedly, the US Food and Drug Administration reevaluates the vCJD risk via use of bovine heparin. We developed a computational model to estimate the vCJD risk to patients receiving bovine heparin injections. The model incorporated information including BSE prevalence, infectivity levels in the intestines, manufacturing batch size, yield of heparin, reduction in infectivity by manufacturing process, and the dose-response relationship. The model estimates a median risk of vCJD infection from a single intravenous dose (10 000 USP units) of heparin made from US-sourced bovine intestines to be 6.9 × 10-9 (2.5-97.fifth percentile: 1.5 × 10-9 -4.3 × 10-8 ), a risk of 1 in 145 million, and 4.6 × 10-8 (2.5-97.fifth percentile: 1.1 × 10-8 -2.6 × 10-7 ), a risk of 1 in 22 million for Canada-sourced products. The model estimates a median risk of 1.4 × 10-7 (...Continue Reading
References
Apr 6, 1996·Lancet·R G WillP G Smith
Dec 10, 1999·American Journal of Infection Control·L L GibsonC N Haas
Dec 22, 1999·Transfusion·P BrownW N Drohan
Sep 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Mike B GravenorAngela R McLean
Sep 9, 2006·Vox Sanguinis·P E HewittR G Will
Feb 7, 2007·The Journal of Veterinary Medical Science·Kazuya Yamanouchi, Yasuhiro Yoshikawa
Oct 8, 2009·Bulletin of the Menninger Clinic·Julie A Luiz AdrianB Christopher Frueh
Apr 14, 2010·Medical Physics·Yimei HuangJay Burmeister
Aug 4, 2010·Analytical and Bioanalytical Chemistry·David A KeireAli Al-Hakim
Aug 23, 2011·PloS One·Helen R Fryer, Angela R McLean
Dec 17, 2011·Emerging Infectious Diseases·Pedro PiccardoDavid M Asher
Apr 17, 2014·PloS One·Chu-Chih Chen, Yin-Han Wang
Sep 19, 2014·Journal of Virology·Yin HuangHong Yang
Jun 10, 2016·Nature Biotechnology·Anita Y SzajekAli Al-Hakim
Jan 25, 2017·The AAPS Journal·Cyrus BettLuisa Gregori
Mar 7, 2017·Transfusion·Hong YangSteven A Anderson
Jun 22, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jan-Ytzen van der MeerLeendert J van den Bos
Apr 24, 2018·Journal of Medical Economics·Ellis J NeufeldJeffrey Spears